GlassScriptPhysician profile
Amanda K Meyer
NPI 1710445432
$912.08
in general payments reported to CMS, 2019-2025
20 companies · $261 in 2025
The $261 reported for 2025 was more than what 81% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $372 · 2022: $202 · 2023: $52.53 · 2024: $24.08 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $169.59 | 2021 | |
| Becton, Dickinson and Company | $169.00 | 2022-2025 | Bd Phaseal, Power-Trialysis |
| Supernus Pharmaceuticals, INC. | $82.67 | 2021-2022 | |
| Adlon Therapeutics L.P. | $74.71 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $65.09 | 2025 | Caplyta |
| Phadia US INC. | $44.49 | 2021-2025 | Immunocap |
| Pfizer INC. | $40.53 | 2025 | |
| Lilly USA, LLC | $35.06 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Merck Sharp & Dohme LLC | $27.99 | 2022-2023 | Vaxneuvance, Gardasil 9, Vaxelis |
| Otsuka America Pharmaceutical, INC. | $27.35 | 2025 | Rexulti |
| Tris Pharma INC | $24.35 | 2023 | Dyanavel Xr |
| Abbvie INC. | $23.01 | 2021 | |
| Ptc Therapeutics, INC. | $22.77 | 2021 | |
| Alkermes, INC. | $20.83 | 2025 | Vivitrol |
| Scilex Pharmaceuticals INC. | $19.62 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $15.54 | 2022 | |
| Exact Sciences Corporation | $14.59 | 2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $14.11 | 2025 | |
| Biomarin Pharmaceutical INC. | $11.29 | 2021 | |
| Cequr Corporation | $9.49 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.